These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19763796)

  • 1. Construction of collagen II/hyaluronate/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering and preliminary analysis of its physico-chemical properties and biocompatibility.
    Li CQ; Huang B; Luo G; Zhang CZ; Zhuang Y; Zhou Y
    J Mater Sci Mater Med; 2010 Feb; 21(2):741-51. PubMed ID: 19763796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regeneration of the intervertebral disc with nucleus pulposus cell-seeded collagen II/hyaluronan/chondroitin-6-sulfate tri-copolymer constructs in a rabbit disc degeneration model.
    Huang B; Zhuang Y; Li CQ; Liu LT; Zhou Y
    Spine (Phila Pa 1976); 2011 Dec; 36(26):2252-9. PubMed ID: 21358466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen II/hyaluronan/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering.
    Huang B; Li CQ; Zhou Y; Luo G; Zhang CZ
    J Biomed Mater Res B Appl Biomater; 2010 Feb; 92(2):322-31. PubMed ID: 19802835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EDC/NHS-crosslinked type II collagen-chondroitin sulfate scaffold: characterization and in vitro evaluation.
    Cao H; Xu SY
    J Mater Sci Mater Med; 2008 Feb; 19(2):567-75. PubMed ID: 18058201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gelatin/chondroitin-6-sulfate copolymer scaffold for culturing human nucleus pulposus cells in vitro with production of extracellular matrix.
    Yang SH; Chen PQ; Chen YF; Lin FH
    J Biomed Mater Res B Appl Biomater; 2005 Jul; 74(1):488-94. PubMed ID: 15912520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of tissue-engineered composite intervertebral disc and preliminary morphological and biochemical evaluation.
    Zhuang Y; Huang B; Li CQ; Liu LT; Pan Y; Zheng WJ; Luo G; Zhou Y
    Biochem Biophys Res Commun; 2011 Apr; 407(2):327-32. PubMed ID: 21382343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of type II collagen and chondroitin sulfate grafted PCL porous scaffold in cartilage tissue engineering.
    Chang KY; Hung LH; Chu IM; Ko CS; Lee YD
    J Biomed Mater Res A; 2010 Feb; 92(2):712-23. PubMed ID: 19274722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study on gelatin-chondroitin sulfate-sodium hyaluronate tri-copolymer as novel scaffolds for cartilage tissue engineering].
    Fan H; Hu Y; Li X; Lu R; Bai J; Wang J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jun; 19(6):473-7. PubMed ID: 16038467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linked collagen-chondroitin sulfate-hyaluronic acid imitating extracellular matrix as scaffold for dermal tissue engineering.
    Wang W; Zhang M; Lu W; Zhang X; Ma D; Rong X; Yu C; Jin Y
    Tissue Eng Part C Methods; 2010 Apr; 16(2):269-79. PubMed ID: 19530938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication and characterization of poly(gamma-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering.
    Chang KY; Cheng LW; Ho GH; Huang YP; Lee YD
    Acta Biomater; 2009 Jul; 5(6):1937-47. PubMed ID: 19282262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate.
    Pieper JS; Oosterhof A; Dijkstra PJ; Veerkamp JH; van Kuppevelt TH
    Biomaterials; 1999 May; 20(9):847-58. PubMed ID: 10226711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II collagen-hyaluronan hydrogel--a step towards a scaffold for intervertebral disc tissue engineering.
    Calderon L; Collin E; Velasco-Bayon D; Murphy M; O'Halloran D; Pandit A
    Eur Cell Mater; 2010 Sep; 20():134-48. PubMed ID: 20821371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of different cross-linking conditions of EDC/NHS on type II collagen scaffolds: an in vitro evaluation.
    Nong LM; Zhou D; Zheng D; Jiang YQ; Xu NW; Zhao GY; Wei H; Zhou SY; Han H; Han L
    Cell Tissue Bank; 2019 Dec; 20(4):557-568. PubMed ID: 31583486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of chondroitin sulfate and hyaluronic acid presence in nanofibers and its alignment on the bone marrow stromal cells: cartilage regeneration.
    Lee P; Tran K; Chang W; Shelke NB; Kumbar SG; Yu X
    J Biomed Nanotechnol; 2014 Aug; 10(8):1469-79. PubMed ID: 25016647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale modification of porous gelatin scaffolds with chondroitin sulfate for corneal stromal tissue engineering.
    Lai JY; Li YT; Cho CH; Yu TC
    Int J Nanomedicine; 2012; 7():1101-14. PubMed ID: 22403490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fabrication of collagen/sodium hyaluronate scaffold and its biological characteristics for cartilage tissue engineering].
    Wu W; Mao T; Feng X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Apr; 21(4):401-5. PubMed ID: 17546888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the carbodiimide cross-linker on the structural and biocompatibility properties of collagen-chondroitin sulfate electrospun mat.
    Akhshabi S; Biazar E; Singh V; Keshel SH; Geetha N
    Int J Nanomedicine; 2018; 13():4405-4416. PubMed ID: 30104874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic nucleus pulposus scaffold created from bovine caudal intervertebral disc tissue utilizing an optimal decellularization procedure.
    Fernandez C; Marionneaux A; Gill S; Mercuri J
    J Biomed Mater Res A; 2016 Dec; 104(12):3093-3106. PubMed ID: 27507100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroprotective supplementation promotes the mechanical properties of injectable scaffold for human nucleus pulposus tissue engineering.
    Foss BL; Maxwell TW; Deng Y
    J Mech Behav Biomed Mater; 2014 Jan; 29():56-67. PubMed ID: 24055794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.
    Pieper JS; Hafmans T; Veerkamp JH; van Kuppevelt TH
    Biomaterials; 2000 Mar; 21(6):581-93. PubMed ID: 10701459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.